Getinge expands ECMO and perfusion digital solutions through acquisition of Talis Clinical
In December 2021, Getinge announced its planned to acquire 100% of the equity interest in U.S.-based Talis Clinical. The company provides high-acuity IT software applications for critical care, cardiac surgery/perfusion, extracorporeal membrane oxygenation (ECMO), anesthesia and labor and delivery. With increasing demand for intelligent solutions to assist in clinical practice, Getinge is hoping to expand its product offerings in this area.
Getinge has a comprehensive portfolio that includes cardiology, but also spans the hospital market with a strong presence in clinical devices sold in several high-acuity care settings, including the ICU and operating room (OR). Getinge offers both devices and supporting IT solutions.
Signify Research, which monitors trends in healthcare technology and IT, said in a recent market report on the acquisition that competition in both the clinical device and associated IT solutions markets is expected to intensify in future years, especially in light of lessons from the pandemic. Signify analyst Kelly Patrick said this means vendors will look at product bundling on devices, IT solutions and consumables to better manage increasing healthcare costs. With this in mind, the vendors with the most comprehensive offerings are expected to see the most success.
How Getinge will leverage Talis Clinical IT solutions
Talis Clinical offers cloud-based IT platforms designed for real-time clinical surveillance to help reduce medical errors and to detect patient deterioration much sooner.
The vendor offers ACG-ECMO, an application that connects data, devices and best practices to help ECMO teams deliver optimal patient outcomes.
The company also offers ACG-RemoteView ICU, a secure, cloud-based mobile web application that creates a remote-view of patient data to support on-premise or virtual-ICU care.
Talis' ACG-Anesthesia is a secure cloud-based clinical application that supports clinical workflow, drives adherence with clinical operational practices, supports complex billing capture and creates compliant documentation.
Patrick explained Getinge is a leading player in the respiratory care and anesthesia device markets, and a smaller player in the IT markets that support these solutions. The increasing demand for intelligent solutions to assist in clinical practice has driven Getinge to assess and enhance its offering to facilitate in the provision of informed patient care. The Talis Clinical offer will further support the Getinge offering enabling both companies to reach a larger customer base and expand into new markets.
Getinge’s device offering is also predominantly focused on the high-end segments in the most critical departments, enabling a core focus market for both companies on these high-end sectors, the Signify analysts said. Although each company currently has a small share in the high-acuity IT market, the combination of both its own and Talis’ digital solutions will expand Getinge’s wider clinical device offering. This will enable Getinge to have more negotiating power in larger purchasing deals that focus on both device and associated digital solutions, further assisting in improving its share in the clinical care market.
Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com